NEW YORK (GenomeWeb) – LifeLabs and GenXys Health Care Systems announced today that they have formed a partnership to offer pharmacogenetic testing services in Canada.

LifeLabs will analyze patient-submitted cheek swab samples to looks for 60 genetic variations that can affect drug metabolism and response. Those results will then be added to GenXys' TreatGxPlus software, which integrates a patient's pharmacogenetic data with information such as age, weight, blood pressure, allergies, other medical conditions, or medications the patient might be taking.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.